---
layout: default
title: Salicylamide
description: "Salicylamide 的老藥新用潛力分析。初步證據等級 L4，包含 10 個預測適應症。查看 AI 預測與臨床證據完整報告。"
parent: 中證據等級 (L3-L4)
nav_order: 153
evidence_level: L4
indication_count: 10
---

# Salicylamide

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
證據等級: <strong>L4</strong> | 預測適應症: <strong>10</strong> 個
</p>

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Salicylamide：從解熱鎮痛到感冒相關疾病

## 一句話總結

<p class="key-answer" data-question="Salicylamide 可以用於治療什麼新適應症？">
Salicylamide 原本用於解熱鎮痛。TxGNN 模型預測它可能對**普通感冒 (common cold)** 及**咽炎 (pharyngitis)** 有效，這些預測獲得多篇歷史文獻支持。
</p>


## 快速總覽

| 項目 | 內容 |
|------|------|
| 原適應症 | 解熱鎮痛、風濕關節痛、神經痛、肌肉痛 |
| 預測新適應症 | pharyngitis、nasal cavity disease、acute laryngopharyngitis、headache disorder、trigeminal autonomic cephalalgia、common cold、allergic urticaria、lung disease、massive neonatal aspiration syndrome、respiratory syncytial virus bronchiolitis |
| TxGNN 預測分數 | 99.93% (咽炎)、99.26% (普通感冒) |
| 證據等級 | L4 |
| 台灣上市 | 已上市 |
| 許可證數 | 119 張（多數已註銷，仍有有效許可證） |
| 建議決策 | Worth Exploring |






## 預測適應症詳細分析

<details class="indication-section" open>
<summary>
<span class="indication-name">1. pharyngitis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.98%</span> <span class="primary-badge">主要分析</span>
</summary>
<div class="indication-content">

<h3>為什麼這個預測合理？</h3>

<p>Salicylamide 是水楊酸的醯胺衍生物，具有以下藥理特性：</p>

<ol>
<li><strong>解熱作用</strong>：抑制前列腺素合成，降低發熱反應。</li>

<li><strong>鎮痛作用</strong>：緩解感冒相關的頭痛、咽喉痛等症狀。</li>

<li><strong>抗發炎作用</strong>：減輕上呼吸道感染相關的發炎反應。</li>

<li><strong>複方製劑經驗</strong>：歷史上常與其他成分組成感冒藥複方，有實際臨床使用經驗。</li>
</ol>

<h3>臨床試驗</h3>

<p>目前無針對此特定適應症的臨床試驗登記。</p>

<h3>相關文獻</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14126993/" target="_blank">14126993</a></td><td>1963</td><td>Article</td><td>Kinderarztliche Praxis</td><td>[EXPERIENCES WITH A NEW ANTIPYRETIC AND ANALGESIC IN A NEW RECTAL CAPSULE FORM].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/5354503/" target="_blank">5354503</a></td><td>1969</td><td>Article</td><td>Minerva medica</td><td>[Double-blind study of 2 bismuth preparations in pharyngo-tonsillitis].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/13060598/" target="_blank">13060598</a></td><td>1953</td><td>Article</td><td>Gazzetta medica italiana</td><td>[Therapy of catarrhal tonsillitis in infancy with o-hydroxybenzamide (salicylami...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. nasal cavity disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.97%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15638142/" target="_blank">15638142</a></td><td>2004</td><td>Article</td><td>Parasite (Paris, France)</td><td>Epidemiology of Oestrus ovis infection of sheep in Argentina&#x27;s Western Pampas.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. acute laryngopharyngitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.97%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. trigeminal autonomic cephalalgia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.94%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. common cold</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.93%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（9 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/13646666/" target="_blank">13646666</a></td><td>1959</td><td>Article</td><td>Scottish medical journal</td><td>Dilacol in the common cold.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2307715/" target="_blank">2307715</a></td><td>1990</td><td>Article</td><td>Journal of chromatography</td><td>Separation and determination of the ingredients of a cold medicine by micellar e...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14447282/" target="_blank">14447282</a></td><td>1961</td><td>Article</td><td>The Practitioner</td><td>A multi-ingredient tablet for the symptomatic relief of the common cold.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8864802/" target="_blank">8864802</a></td><td>1996</td><td>Article</td><td>International journal of clini</td><td>Salicylamide toxicity in overdose.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23212937/" target="_blank">23212937</a></td><td>2013</td><td>Article</td><td>Journal of human lactation : o</td><td>Raynaud&#x27;s phenomenon of the nipple associated with labetalol use.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8952318/" target="_blank">8952318</a></td><td>1996</td><td>Article</td><td>Nihon Rinsho Men&#x27;eki Gakkai ka</td><td>[Drug induced hemolytic anemia associated with agranulocytosis].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6760679/" target="_blank">6760679</a></td><td>1982</td><td>Article</td><td>Acta medica Scandinavica. Supp</td><td>Antihypertensive and metabolic effects of increasing doses of atenolol and labet...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14493422/" target="_blank">14493422</a></td><td>1962</td><td>Article</td><td>Praxis</td><td>[Serial studies with a larger group for the testing of the prophylactic and ther...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/5719890/" target="_blank">5719890</a></td><td>1968</td><td>Article</td><td>Der Landarzt</td><td>[On experiences with Donaran in the treatment of colds in a home for children].</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. allergic urticaria</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.65%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（3 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6338062/" target="_blank">6338062</a></td><td>1983</td><td>Article</td><td>Journal of the American Academ</td><td>Phototoxicity and photoallergy in man.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6606363/" target="_blank">6606363</a></td><td>1983</td><td>Article</td><td>The American journal of medici</td><td>Antipyretic analgesics and the allergic patient.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38330800/" target="_blank">38330800</a></td><td>2024</td><td>Article</td><td>International immunopharmacolo</td><td>Serum IgA contributes to the comprehension of Anisakis simplex associated chroni...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. lung disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.64%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（20 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29808264/" target="_blank">29808264</a></td><td>2019</td><td>Article</td><td>Pediatric nephrology (Berlin, </td><td>Neonatal hypertension: cases, causes, and clinical approach.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38949541/" target="_blank">38949541</a></td><td>2024</td><td>Article</td><td>Obstetrics and gynecology</td><td>Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of M...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36905090/" target="_blank">36905090</a></td><td>2023</td><td>Article</td><td>Medicinal research reviews</td><td>Therapeutic potential of salicylamide derivatives for combating viral infections...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6399864/" target="_blank">6399864</a></td><td>1984</td><td>Article</td><td>Cardiology clinics</td><td>Hypertensive crisis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34664162/" target="_blank">34664162</a></td><td>2021</td><td>Article</td><td>Molecular biology reports</td><td>Niclosamide for Covid-19: bridging the gap.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37573365/" target="_blank">37573365</a></td><td>2023</td><td>Article</td><td>Nature communications</td><td>Identification of a drug binding pocket in TMEM16F calcium-activated ion channel...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40650414/" target="_blank">40650414</a></td><td>2025</td><td>Article</td><td>IUBMB life</td><td>A New Treatment Strategy for Lung Cancer With HDAC and Wnt/β-Catenin Pathway Inh...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6370541/" target="_blank">6370541</a></td><td>1984</td><td>Article</td><td>Clinical pharmacokinetics</td><td>Clinical pharmacokinetics of labetalol.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31037769/" target="_blank">31037769</a></td><td>2019</td><td>Article</td><td>Journal of cellular biochemist</td><td>Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37450704/" target="_blank">37450704</a></td><td>2023</td><td>Article</td><td>Journal of cellular biochemist</td><td>Targeting the epithelial-mesenchymal transition (EMT) pathway with combination o...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31446534/" target="_blank">31446534</a></td><td>2020</td><td>Article</td><td>Investigational new drugs</td><td>Effects of salinomycin and niclosamide on small cell lung cancer and small cell ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32132037/" target="_blank">32132037</a></td><td>2020</td><td>Article</td><td>Anticancer research</td><td>Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29257330/" target="_blank">29257330</a></td><td>2018</td><td>Article</td><td>Molecular medicine reports</td><td>Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant hu...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29910813/" target="_blank">29910813</a></td><td>2018</td><td>Article</td><td>Frontiers in immunology</td><td>S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17972234/" target="_blank">17972234</a></td><td>2007</td><td>Article</td><td>American journal of perinatolo</td><td>Goodpasture&#x27;s disease in pregnancy: case report and review of the literature.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34155207/" target="_blank">34155207</a></td><td>2021</td><td>Article</td><td>Nature communications</td><td>SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10219/" target="_blank">10219</a></td><td>1975</td><td>Article</td><td>Gastroenterologia Japonica</td><td>Salycylamide glucuronide formation in liver disease and its change by drugs.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39245099/" target="_blank">39245099</a></td><td>2024</td><td>Article</td><td>International journal of biolo</td><td>Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted ab...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27127879/" target="_blank">27127879</a></td><td>2016</td><td>Article</td><td>Oncotarget</td><td>S100A4 drives non-small cell lung cancer invasion, associates with poor prognosi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31391337/" target="_blank">31391337</a></td><td>2019</td><td>Article</td><td>JCI insight</td><td>Niclosamide repurposed for the treatment of inflammatory airway disease.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. massive neonatal aspiration syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.58%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. respiratory syncytial virus bronchiolitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.56%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. hantavirus infectious disease</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.53%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>


## 台灣上市資訊

| 許可證號 | 品名 | 劑型 | 狀態 | 核准適應症 |
|---------|------|------|------|-----------|
| 衛部藥輸字第027398號 | 水楊醯胺 | 粉末 | 有效 | 鎮痛藥 |
| 衛署藥製字第020224號 | "人生"必治僂糖衣錠 | 糖衣錠 | 有效 | 退燒、止痛 |
| 衛署藥製字第022383號 | "生達"安治痛錠 | 錠劑 | 有效 | 退燒、止痛 |

## 安全性考量

### 藥物交互作用

目前 DDInter 資料庫中無 Salicylamide 的重大藥物交互作用記錄。

### 特殊注意事項

- **過量毒性**：有文獻報告過量使用導致毒性反應
- **肝代謝**：主要經葡萄糖醛酸化代謝，肝功能不全者需注意
- **類水楊酸反應**：可能發生類似阿斯匹靈的過敏反應

### 與阿斯匹靈的差異

根據文獻，阿斯匹靈過敏的患者可能可以安全使用 Salicylamide，因為其抑制環氧化酶的能力較弱。

## 結論與下一步

**決策：Worth Exploring**

**理由：**
1. 藥理機轉支持其用於感冒相關症狀
2. 有歷史臨床使用經驗和文獻支持
3. 台灣仍有有效許可證
4. 安全性特徵相對良好

**若要推進需要：**
- 現代化的隨機對照試驗評估療效
- 標準化劑量和給藥方案
- 與現有感冒藥物的比較性研究
- 考慮複方製劑的開發可能性


---

## 相關藥物報告

- [Hydroquinone]({{ "/drugs/hydroquinone/" | relative_url }}) - 證據等級 L4
- [Brodalumab]({{ "/drugs/brodalumab/" | relative_url }}) - 證據等級 L4
- [Minoxidil]({{ "/drugs/minoxidil/" | relative_url }}) - 證據等級 L4
- [Probenecid]({{ "/drugs/probenecid/" | relative_url }}) - 證據等級 L4
- [Acebutolol]({{ "/drugs/acebutolol/" | relative_url }}) - 證據等級 L4

---

{% include ai-analysis.html %}

{% include social-share.html %}

## 引用本報告

如需引用本報告，請使用以下格式：

**APA 格式：**
```
TwTxGNN. (2026). Salicylamide老藥新用驗證報告. https://twtxgnn.yao.care/drugs/salicylamide/
```

**BibTeX 格式：**
```bibtex
@misc{twtxgnn_salicylamide,
  title = {Salicylamide老藥新用驗證報告},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/salicylamide/}
}
```

---

<div class="disclaimer">
<strong>免責聲明</strong><br>
本報告僅供學術研究參考，<strong>不構成醫療建議</strong>。藥物使用請遵循醫師指示，切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
<br><br>
<small>最後審核：2026-02-20 | 審核者：TwTxGNN Research Team</small>
</div>

{% include giscus.html %}
